EAACI Congress 2025
BackFT21 - Allergic rhinitis: updates on epidemiology, diagnostics, and novel therapy
Sunday 15 Jun, 17:30 PM -
19:00 PM Glasgow, United Kingdom
Dochart 2
Flash Talks
17:30
Allergic rhinitis: Incidence and remission from childhood to adulthood in a Swedish cohort
17:37
Has climate change already impacted the epidemiology of allergic sensitisation in the UK and how might it affect clinical allergy?
17:44
Association Between Allergic Rhinitis and Nasal Septum Deviation in Children: Results from the ARHINASD Study
17:51
Validation of a Skin Prick Automated Test (SPAT) cutoff value in birch pollen and house dust mite clinically allergic patients
17:58
Can the Dermatophagoides Pteronyssinus Molecular Allergen Sensitization Profile, assessed with a Skin Prick Test, Be Useful in Evaluating Clinically Relevant House Dust Mite Allergy?
18:05
Corneal topography parameters among children with systemic allergic diseases or allergic conjunctivitis: a cross-sectional observational study
18:12
Using an Environmental Exposure Chamber (EEC) to Conduct Allergy Trials Mitigates Trial Disruptions and Provides Consistent Drug Testing Outcomes after the Trial is Resumed
18:19
Operational performance of the Nasal Provocation Test in determining the frequency of allergy to Blomia tropicalis in sensitized patients at an allergy center: A 5-year follow-up
18:26
MY010: An Anti-Allergen Multispecific for the Treatment of Multiple Tree Pollen Allergies
18:33
Onset of Action (OOA) and Efficacy of Azelastine Hydrochloride 0.15% Nasal Spray (AZNS) on Allergy Symptoms in an Environmental Exposure Chamber (EEC) Compared to Placebo (PL) and Mometasone Furoate/Olopatadine Hydrochloride NS (MFONS)
